Endothelial dysfunction in DOCA-salt hypertension - Possible involvement of prostaglandin endoperoxides


Autoria(s): Cordellini, S.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

01/03/1999

Resumo

The effects of the arachidonic acid metabolism inhibitors on the acetylcholine responses of aortae from control (CR) and deoxycorticosterone acetate (DOCA)-salt hypertensive (HR) rats were investigated. The acetylcholine decreased response observed in HR [relaxation (%): CR 95.5 +/- 2.7, n = 4; HR 52.0 +/- 6.3, n = 5, p < 0.05] was restored by the cyclooxygenase inhibitor piroxicam [relaxation (%): CR 99.8 +/- 0.2, n = 4; HR 86.0 +/- 4.0, n = 5] and by the thromboxane synthetase inhibitor and the thrombox ane A(2)/prostaglandin H-2 receptor antagonist ridogrel [relaxation (%): CR 92.1 +/- 4.4, n = 7; HR 93.1 +/- 2.0, n = 7] but not by the inhibitors of thromboxane synthetase, prostacyclin synthetase, cytochrome P-450 monooxygenase, and lipoxygenase. So, endoperoxide intermediates seem to be involved in the decreased endothelium-dependent relaxation to acetylcholine in DOCA-salt hypertension. (C) 1999 Elsevier B.V. All rights reserved.

Formato

315-320

Identificador

http://dx.doi.org/10.1016/S0306-3623(98)00188-8

General Pharmacology. Oxford: Pergamon-Elsevier B.V., v. 32, n. 3, p. 315-320, 1999.

0306-3623

http://hdl.handle.net/11449/37431

10.1016/S0306-3623(98)00188-8

WOS:000079560700005

Idioma(s)

eng

Publicador

Elsevier B.V.

Relação

General Pharmacology

Direitos

closedAccess

Palavras-Chave #DOCA-salt hypertension #arachidonic acid metabolism inhibitors #endothelium-derived contracting factor #prostaglandin endoperoxide intermediates #rat aorta #acetylcholine
Tipo

info:eu-repo/semantics/article